Stay updated on Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:25:59.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434, and the site revision advances from v3.7.1 to v3.7.2. The study record remains behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T23:07:55.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:13:59.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The 403 Forbidden error page (and the Home link) was removed, and the page now shows the standard study details layout with navigation.
    Difference
    0.5%
    Check dated 2026-09-29T23:22:01.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A 403 Forbidden error page replaces the study record content, indicating the page is currently inaccessible to users. This prevents viewing trial details and related information on that record.
    Difference
    17%
    Check dated 2026-09-22T23:24:12.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.6 to v3.7.0, indicating a new version of the page metadata. This represents a new version of the page without indicating substantive changes to the study information.
    Difference
    0.1%
    Check dated 2026-09-15T22:28:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.